References
- Rake M O, Flute P T, Pannel P T, Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet 1970; 1: 533–537
- Rake M O, Flute P T, Shilkin K B, Lewis M L, Winch J, Williams R. Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet 1971; 2: 1215–1219
- Wilkinson S P, Arroyo V, Gazzard B G, Moodie H, Williams R. Relationship of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet 1974; 1: 521–524
- Vestraete M, Vermylen J, Collen D. Intravascular coagulation in liver diseases. Annu Rev Med 1974; 25: 447–455
- Egbring R, Seitz R, Blanke H, et al. The proteinase inhibitor complexes (antithrombin III—thrombin, alpha 2 antiplasmin-plasmin and alpha 1 antitrypsinelastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome. Behring Inst Mitt 1986; 79: 87–103
- Takahashi H, Tatewaki W, Wada K, Yoshikawa K, Shibata A. Thrombin and plasmin generation in patients with liver disease. Am J Hematol 1989; 32: 30–35
- Tomiya T, Ogata J, Fujiwara K. Inhibition of thrombin generation in fulminant hepatic failure by treatment with antithrombin III. Biochemical Progress 1989; 2: 39–40
- Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101–106
- Mimuro J, Koike Y, Sumi Y, Aoki N. Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor. Blood 1987; 69: 446–453
- Flute P T. Blood coagulation defects in FHF. Am J Gastroenterol 1978; 69: 363–364
- Hillenbrand P, Parbhoo S P, Jedrychowski A, Sherlock S. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure. Gut 1974; 15: 83–88
- Dymock I W, Tucker J S, Woolf I L, Poller L, Thomson J S. Coagulation studies as a prognostic index in acute liver failure. Br J Haematol 1975; 29: 385–395
- Rake M O, Flute P T, Pannel G, Shilkin K B, Williams R. Experimental hepatic necrosis: Studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen. Gut 1973; 14: 574–580
- Clark R, Rake M O, Flute P T, Williams R. Coagulation abnormalities in acute liver failure; pathogenesis and therapeutic implications. Scand J Gastroenterol 1973; 8(suppl)63–70
- Vogel G E. Early treatment with AT III in acute liver failure. Behring Inst Mitt 1983; 73: 79–93
- Fujiwara K, Ogata I, Ohta Y, et al. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut 1988; 29: 1103–1108
- Fujiwara K, Okita K, Akamatsu K, et al. Antithrombin III concentrate in the treatment of fulminant hepatic failure. Gastroenterol Jpn 1988; 23: 423–427